Host: Pavani Chalasani, MD, MPH
Guest: Aditya Bardia, MD, MPH

For patients with hormone receptor-positive HER 2-negative metastatic breast, treatment can be challenging. But what treatment options are available? Lead investigator from the EMERALD trial Dr. Aditya Bardia joins Dr. Pavani Chalasani to share his insights.